Off-label targeted therapy (TT) use in recurrent/metastatic NSCLC.

e18688Background: Comprehensive genomic profiling (CGP) is an established diagnostic approach to select patients for TT. As CGP gains wide adoption, an increasing number of patients are found to ha...